Efficacy of a Web App for Cognitive Training (MeMo) Regarding Cognitive and Behavioral Performance in People With Neurocognitive Disorders: Randomized Controlled Trial

Philippe Robert, Valeria Manera, Alexandre Derreumaux, Marion Ferrandez Y Montesino, Elsa Leone, Roxane Fabre, Jeremy Bourgeois, Philippe Robert, Valeria Manera, Alexandre Derreumaux, Marion Ferrandez Y Montesino, Elsa Leone, Roxane Fabre, Jeremy Bourgeois

Abstract

Background: Cognitive and behavioral symptoms are the clinical hallmarks of neurocognitive disorders. Cognitive training may be offered to reduce the risks of cognitive decline and dementia and to reduce behavioral symptoms, such as apathy. Information and communication technology approaches, including serious games, can be useful in improving the playful aspect of computerized cognitive training and providing motivating solutions in elderly patients.

Objective: The objective of this study was to assess the effectiveness of employing the MeMo (Memory Motivation) Web app with regard to cognitive and behavioral symptoms in patients with neurocognitive disorders.

Methods: MeMo is a Web app that can be used on any Web browser (computer or tablet). The training activities proposed in MeMo are divided into the following two parts: memory and mental flexibility/attention. The study included 46 individuals (mean age 79.4 years) with a diagnosis of neurocognitive disorders at the Institut Claude Pompidou Memory Center in Nice. This randomized controlled study compared the evolution of cognition and behavior between patients not using MeMo (control group) and patients using MeMo (MeMo group) for 12 weeks (four sessions per week). Patients underwent memory and attention tests, as well as an apathy assessment at baseline, week 12 (end of the training period), and week 24 (12 weeks after the end of the training sessions). In addition, to assess the impact of high and low game uses, the MeMo group was divided into patients who used MeMo according to the instructions (about once every 2 days; active MeMo group) and those who used it less (nonactive MeMo group).

Results: When comparing cognitive and behavioral scores among baseline, week 12, and week 24, mixed model analysis for each cognitive and behavioral score indicated no significant interaction between testing time and group. On comparing the active MeMo group (n=9) and nonactive MeMo group (n=13), there were significant differences in two attention tests (Trial Making Test A [P=.045] and correct Digit Symbol Substitution Test items [P=.045]) and in the Apathy Inventory (AI) (P=.02). Mixed analysis (time: baseline, week 12, and week 24 × number of active days) indicated only one significant interaction for the AI score (P=.01), with a significant increase in apathy in the nonactive MeMo group.

Conclusions: This study indicates that the cognitive and behavioral efficacies of MeMo, a Web-based training app, can be observed only with regular use of the app. Improvements were observed in attention and motivation.

Trial registration: ClinicalTrials.gov NCT04142801; https://ichgcp.net/clinical-trials-registry/NCT04142801.

Keywords: Alzheimer disease; apathy; cognition; intervention; motivation; neurocognitive disorders.

Conflict of interest statement

Conflicts of Interest: None declared.

©Philippe Robert, Valeria Manera, Alexandre Derreumaux, Marion Ferrandez Y Montesino, Elsa Leone, Roxane Fabre, Jeremy Bourgeois. Originally published in the Journal of Medical Internet Research (http://www.jmir.org), 11.03.2020.

Figures

Figure 1
Figure 1
Apathy Inventory score changes in the active MeMo group and nonactive MeMo group. MeMo: Memory Motivation.

References

    1. Cummings J. Cognitive and behavioral heterogeneity in Alzheimer's disease: seeking the neurobiological basis. Neurobiol Aging. 2000;21(6):845–61. doi: 10.1016/s0197-4580(00)00183-4.
    1. Ngandu T, Lehtisalo J, Solomon A, Levälahti E, Ahtiluoto S, Antikainen R, Bäckman L, Hänninen T, Jula A, Laatikainen T, Lindström J, Mangialasche F, Paajanen T, Pajala S, Peltonen M, Rauramaa R, Stigsdotter-Neely A, Strandberg T, Tuomilehto J, Soininen H, Kivipelto M. A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial. The Lancet. 2015 Jun;385(9984):2255–2263. doi: 10.1016/S0140-6736(15)60461-5.
    1. Rosenberg A, Mangialasche F, Ngandu T, Solomon A, Kivipelto M. Multidomain Interventions to Prevent Cognitive Impairment, Alzheimer's Disease, and Dementia: From FINGER to World-Wide FINGERS. J Prev Alzheimers Dis. 2020;7(1):29–36. doi: 10.14283/jpad.2019.41.
    1. Clare L, Woods RT. Cognitive training and cognitive rehabilitation for people with early-stage Alzheimer's disease: A review. Neuropsychological Rehabilitation. 2004 Sep;14(4):385–401. doi: 10.1080/09602010443000074.
    1. Butler M, McCreedy E, Nelson VA, Desai P, Ratner E, Fink HA, Hemmy LS, McCarten JR, Barclay TR, Brasure M, Davila H, Kane RL. Does Cognitive Training Prevent Cognitive Decline? Ann Intern Med. 2017 Dec 19;168(1):63. doi: 10.7326/m17-1531.
    1. World Health Organization . Global Action Plan on the Public Health Response to Dementia, 2017-2025. Geneva: World Health Organization; 2017.
    1. Ge S, Zhu Z, Wu B, McConnell ES. Technology-based cognitive training and rehabilitation interventions for individuals with mild cognitive impairment: a systematic review. BMC Geriatr. 2018 Sep 15;18(1):213. doi: 10.1186/s12877-018-0893-1.
    1. Hill NT, Mowszowski L, Naismith SL, Chadwick VL, Valenzuela M, Lampit A. Computerized Cognitive Training in Older Adults With Mild Cognitive Impairment or Dementia: A Systematic Review and Meta-Analysis. Am J Psychiatry. 2017 Apr 01;174(4):329–340. doi: 10.1176/appi.ajp.2016.16030360.
    1. van Dalen JW, van Wanrooij LL, Moll van Charante EP, Brayne C, van Gool WA, Richard E. Association of Apathy With Risk of Incident Dementia: A Systematic Review and Meta-analysis. JAMA Psychiatry. 2018 Oct 01;75(10):1012–1021. doi: 10.1001/jamapsychiatry.2018.1877.
    1. Levy R, Dubois B. Apathy and the functional anatomy of the prefrontal cortex-basal ganglia circuits. Cereb Cortex. 2006 Jul;16(7):916–28. doi: 10.1093/cercor/bhj043.
    1. Robert P, Lanctôt KL, Agüera-Ortiz L, Aalten P, Bremond F, Defrancesco M, Hanon C, David R, Dubois B, Dujardin K, Husain M, König A, Levy R, Mantua V, Meulien D, Miller D, Moebius H, Rasmussen J, Robert G, Ruthirakuhan M, Stella F, Yesavage J, Zeghari R, Manera V. Is it time to revise the diagnostic criteria for apathy in brain disorders? The 2018 international consensus group. Eur Psychiatry. 2018 Oct;54:71–76. doi: 10.1016/j.eurpsy.2018.07.008.
    1. Husain M, Roiser JP. Neuroscience of apathy and anhedonia: a transdiagnostic approach. Nat Rev Neurosci. 2018 Aug 26;19(8):470–484. doi: 10.1038/s41583-018-0029-9.
    1. Ruthirakuhan M, Herrmann N, Vieira D, Gallagher D, Lanctôt KL. The Roles of Apathy and Depression in Predicting Alzheimer Disease: A Longitudinal Analysis in Older Adults With Mild Cognitive Impairment. Am J Geriatr Psychiatry. 2019 Aug;27(8):873–882. doi: 10.1016/j.jagp.2019.02.003.
    1. Benoit M, Guerchouche R, Petit PD, Chapoulie E, Manera V, Chaurasia G, Drettakis G, Robert P. Is it possible to use highly realistic virtual reality in the elderly? A feasibility study with image-based rendering. Neuropsychiatr Dis Treat. 2015;11:557–63. doi: 10.2147/NDT.S73179. doi: 10.2147/NDT.S73179.
    1. Manera V, Petit P, Derreumaux A, Orvieto I, Romagnoli M, Lyttle G, David R, Robert PH. 'Kitchen and cooking,' a serious game for mild cognitive impairment and Alzheimer's disease: a pilot study. Front Aging Neurosci. 2015 Mar 17;7:24. doi: 10.3389/fnagi.2015.00024. doi: 10.3389/fnagi.2015.00024.
    1. Manera V, Abrahams S, Agüera-Ortiz L, Bremond F, David R, Fairchild K, Gros A, Hanon C, Husain M, König A, Lockwood PL, Pino M, Radakovic R, Robert G, Slachevsky A, Stella F, Tribouillard A, Trimarchi PD, Verhey F, Yesavage J, Zeghari R, Robert P. Recommendations for the Nonpharmacological Treatment of Apathy in Brain Disorders. Am J Geriatr Psychiatry. 2019 Aug 09; doi: 10.1016/j.jagp.2019.07.014.
    1. Aalbers T, Baars MA, Olde Rikkert MG, Kessels RP. Puzzling with online games (BAM-COG): reliability, validity, and feasibility of an online self-monitor for cognitive performance in aging adults. J Med Internet Res. 2013 Dec 03;15(12):e270. doi: 10.2196/jmir.2860.
    1. König A, Satt A, Sorin A, Hoory R, Toledo-Ronen O, Derreumaux A, Manera V, Verhey F, Aalten P, Robert PH, David R. Automatic speech analysis for the assessment of patients with predementia and Alzheimer's disease. Alzheimers Dement (Amst) 2015 Mar;1(1):112–24. doi: 10.1016/j.dadm.2014.11.012.
    1. Manera V, Ben-Sadoun G, Aalbers T, Agopyan H, Askenazy F, Benoit M, Bensamoun D, Bourgeois J, Bredin J, Bremond F, Crispim-Junior C, David R, De Schutter B, Ettore E, Fairchild J, Foulon P, Gazzaley A, Gros A, Hun S, Knoefel F, Olde Rikkert M, Phan Tran MK, Politis A, Rigaud AS, Sacco G, Serret S, Thümmler S, Welter ML, Robert P. Recommendations for the Use of Serious Games in Neurodegenerative Disorders: 2016 Delphi Panel. Front Psychol. 2017;8:1243. doi: 10.3389/fpsyg.2017.01243. doi: 10.3389/fpsyg.2017.01243.
    1. Robert PH, König A, Amieva H, Andrieu S, Bremond F, Bullock R, Ceccaldi M, Dubois B, Gauthier S, Kenigsberg P, Nave S, Orgogozo JM, Piano J, Benoit M, Touchon J, Vellas B, Yesavage J, Manera V. Recommendations for the use of Serious Games in people with Alzheimer's Disease, related disorders and frailty. Front Aging Neurosci. 2014 Mar 24;6:54. doi: 10.3389/fnagi.2014.00054. doi: 10.3389/fnagi.2014.00054.
    1. Zyda M. From visual simulation to virtual reality to games. Computer. 2005 Sep;38(9):25–32. doi: 10.1109/mc.2005.297.
    1. Ben-Sadoun G, Manera V, Alvarez J, Sacco G, Robert P. Recommendations for the Design of Serious Games in Neurodegenerative Diseases. Front Aging Neurosci. 2018 Feb 2;10:13. doi: 10.3389/fnagi.2018.00013. doi: 10.3389/fnagi.2018.00013.
    1. Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”. Journal of Psychiatric Research. 1975 Nov;12(3):189–198. doi: 10.1016/0022-3956(75)90026-6.
    1. American Psychiatric Association . Diagnostic and Statistical Manual of Mental Disorders: DSM-5. Washington, DC: American Psychiatric Association; 2013.
    1. Jorm AF, Jacomb PA. The Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE): socio-demographic correlates, reliability, validity and some norms. Psychol Med. 1989 Nov 09;19(4):1015–22. doi: 10.1017/s0033291700005742.
    1. Grober E, Buschke H, Crystal H, Bang S, Dresner R. Screening for dementia by memory testing. Neurology. 1988 Jun 01;38(6):900–3. doi: 10.1212/wnl.38.6.900.
    1. Lezak M. Neuropsychological Assessment, 3rd Ed. Oxford, United Kingdom: Oxford University Press; 1995.
    1. Dubois B, Slachevsky A, Litvan I, Pillon B. The FAB: a Frontal Assessment Battery at bedside. Neurology. 2000 Dec 12;55(11):1621–6. doi: 10.1212/wnl.55.11.1621.
    1. Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, Gornbein J. The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology. 1994 Dec 01;44(12):2308–14. doi: 10.1212/wnl.44.12.2308.
    1. Robert PH, Clairet S, Benoit M, Koutaich J, Bertogliati C, Tible O, Caci H, Borg M, Brocker P, Bedoucha P. The apathy inventory: assessment of apathy and awareness in Alzheimer's disease, Parkinson's disease and mild cognitive impairment. Int J Geriatr Psychiatry. 2002 Dec;17(12):1099–105. doi: 10.1002/gps.755.
    1. Isik AT, Soysal P, Solmi M, Veronese N. Bidirectional relationship between caregiver burden and neuropsychiatric symptoms in patients with Alzheimer's disease: A narrative review. Int J Geriatr Psychiatry. 2019 Sep 10;34(9):1326–1334. doi: 10.1002/gps.4965.
    1. Sood P, Kletzel S, Krishnan S, Devos H, Negm A, Hoffecker L, Machtinger J, Hu X, Heyn PC. Nonimmersive Brain Gaming for Older Adults With Cognitive Impairment: A Scoping Review. Gerontologist. 2019 Nov 16;59(6):e764–e781. doi: 10.1093/geront/gny164.
    1. Basak C, Boot WR, Voss MW, Kramer AF. Can training in a real-time strategy video game attenuate cognitive decline in older adults? Psychol Aging. 2008 Dec;23(4):765–77. doi: 10.1037/a0013494.
    1. Miller KJ, Dye RV, Kim J, Jennings JL, O'Toole E, Wong J, Siddarth P. Effect of a computerized brain exercise program on cognitive performance in older adults. Am J Geriatr Psychiatry. 2013 Jul;21(7):655–63. doi: 10.1016/j.jagp.2013.01.077.
    1. Manera V, Fabre R, Stella F, Loureiro JC, Agüera-Ortiz L, López-Álvarez J, Hanon C, Hoertel N, Aalten P, Ramakers I, Zeghari R, Robert P. A survey on the prevalence of apathy in elderly people referred to specialized memory centers. Int J Geriatr Psychiatry. 2019 Oct;34(10):1369–1377. doi: 10.1002/gps.5125.
    1. Benoit M, Robert PH. Imaging correlates of apathy and depression in Parkinson's disease. J Neurol Sci. 2011 Nov 15;310(1-2):58–60. doi: 10.1016/j.jns.2011.07.006.
    1. Ben-Sadoun G, Sacco G, Manera V, Bourgeois J, König A, Foulon P, Fosty B, Bremond F, d’Arripe-Longueville F, Robert P. Physical and Cognitive Stimulation Using an Exergame in Subjects with Normal Aging, Mild and Moderate Cognitive Impairment. JAD. 2016 Aug 08;53(4):1299–1314. doi: 10.3233/jad-160268.
    1. Booth V, Harwood R, Hancox JE, Hood-Moore V, Masud T, Logan P. Motivation as a mechanism underpinning exercise-based falls prevention programmes for older adults with cognitive impairment: a realist review. BMJ Open. 2019 Jun 19;9(6):e024982. doi: 10.1136/bmjopen-2018-024982.
    1. Lee GY, Yip CC, Yu EC, Man DW. Evaluation of a computer-assisted errorless learning-based memory training program for patients with early Alzheimer's disease in Hong Kong: a pilot study. Clin Interv Aging. 2013;8:623–33. doi: 10.2147/CIA.S45726. doi: 10.2147/CIA.S45726.
    1. Entertainment Software Association Entertainment Software Association. 2019. [2020-02-17]. 2019 Essential Facts About the Computer and Video Game Industry
    1. Mishra J, Anguera JA, Gazzaley A. Video Games for Neuro-Cognitive Optimization. Neuron. 2016 Apr 20;90(2):214–8. doi: 10.1016/j.neuron.2016.04.010.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe